IOVANCE BIOTHERAPEUTICS, INC. Preferred Stock, Value, Issued
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Preferred Stock, Value, Issued of $0 as of 2016-03-31, per its 10-Q filed 2016-05-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2016-05-09
- 2016-03-31: Preferred Stock, Value, Issued $0.00.
- 2015-12-31: Preferred Stock, Value, Issued $0.00.
- 2015-06-30: Preferred Stock, Value, Issued $4.00.
- 2015-03-31: Preferred Stock, Value, Issued $4.00.
| Period end | Preferred Stock, Value, Issued | Preferred Stock, Value, Issued as first filed |
|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $0.00 10-Q · filed 2016-05-09 | |
| 2015-06-30 | $4.00 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $4.00 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 | $6.00 10-K · filed 2015-03-16 |
| 2014-09-30 | $6.00 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $6.00 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $13.00 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $17.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |